WRIB

8th Workshop on Recent Issues in Bioanalysis (8th WRIB)

Where Regulators and the Industry Convene

New Challenges in Method Development, Emerging Approaches for Regulated Bioanalysis from Discovery Bioanalysis
And Latest Regulatory Updates/Findings on Multiple Harmonized Guidances around the Globe

Hilton Los Angeles/Universal City

March 10 - 14, 2014, Universal City, CA, USA

Hilton Los Angeles/Universal City Hotel

Atop Hollywood Hills

Highlight   |   White Papers from WRIB   |   Sponsors   |   Provide Your Feedbacks for Improvement  

 

Close to 500 professionals representing large pharmas, biotechs, CROs and multiple regulatory agencies working on both small and large molecules bioanalysis participated in the 8th WRIB (Workshop on Recent Issues in Bioanalysis) on March 10-14, 2014 in Los Angeles/Universal City, California. The 2014 White Paper in Bioanalysis from this meeting will be published in the August 2014 Issue of Bioanaysis Journal.

The 8th WRIB featured a novel and unique 3-day sequential program with no parallel/overlapping sessions specifically designed to maximize the learning process at any level in your field of expertise: Small Molecules, Large Molecules, LCMS, LBA and Immunogenicity.

In addition to the 3-day main workshop, 6 training courses (LCMS, LBA and Hybrid LBA/LCMS) were evenly spread to allow the flexibility to choose different combination of courses & workshop days based on your track of interest:

  • 5-day Full Immersion in Bioanalysis (March 10-14)
  • 4-day LCMS Track (March 10-13)
  • 4-day LBA and Immunogenicity Track (March 11-14)

Participating Regulators at 8th WRIB included the followings:

  • US FDA
    • BMV: LCMS and LBA
    • Immunogenicity
  • Europe EMA
    • BMV: LCMS
    • BMV: LBA
  • Japan MHLW
    • BMV: LCMS
    • BMV: LBA
  • Health Canada
  • UK MHRA
  • Dutch MEB
  • France ANSM
  • Austria AGES
  • Germany BfArM

Like the previous editions, this 8th WRIB was again

  • Very practical with a variety of hot topics/contents;
  • Highly interactive with thought-provoking Q&A dialogs and panel discussions
  • Very informative with the active participation from global regulatory agencies
  • Well formulated with excellent balance of science, regulation and process

High quality, better compliance to regulations and scientific excellence have been and will always be the foundation of the WRIB!

We look forward to seeing you at the next WRIB - 9th WRIB in Miami Florida!

 

©2012 CFABS. All Rights Reserved.